Resistance to Acetylsalicylic Acid in Patients with Coronary Heart Disease Is the Result of Metabolic Activity of Platelets

Sensitivity to acetylsalicylic acid (ASA) is important in the treatment of patients with coronary heart disease (CHD) after coronary artery bypass grafting (CABG). Patients were divided into ASA sensitive (sASA) and ASA resistant (rASA) by the activity of platelet aggregation induced arachidonic aci...

Full description

Bibliographic Details
Main Authors: Yuriy I. Grinshtein, Andrei A. Savchenko, Aleksandra A. Kosinova, Maxim D. Goncharov
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/13/8/178
_version_ 1797560612906074112
author Yuriy I. Grinshtein
Andrei A. Savchenko
Aleksandra A. Kosinova
Maxim D. Goncharov
author_facet Yuriy I. Grinshtein
Andrei A. Savchenko
Aleksandra A. Kosinova
Maxim D. Goncharov
author_sort Yuriy I. Grinshtein
collection DOAJ
description Sensitivity to acetylsalicylic acid (ASA) is important in the treatment of patients with coronary heart disease (CHD) after coronary artery bypass grafting (CABG). Patients were divided into ASA sensitive (sASA) and ASA resistant (rASA) by the activity of platelet aggregation induced arachidonic acid (ARA) together with ASA. Induced platelet aggregation activity was studied in sASA and rASA patients with CHD before and after CABG. The level of synthesis of primary and secondary reactive oxygen species (ROS) by platelets was determined using chemiluminescent analysis. The activity of NAD- and NADP-dependent dehydrogenases in platelets was determined by the bioluminescent method. It was found that the aggregation activity of platelets depended on the sensitivity of CHD patients to ASA and decreased during postoperative ASA therapy. The most pronounced differences in metabolic parameters of platelets in sASA and rASA patients were detected by Nox2 activity. The synthesis of secondary ROS by platelets of CHD patients did not depend on the sensitivity of patients to ASA but increased during postoperative treatment with ASA. The activity of NAD(P)-dependent dehydrogenases in platelets did not differ in sASA and rASA patients with CHD.
first_indexed 2024-03-10T18:02:11Z
format Article
id doaj.art-694f6ae05d04452a82b535d441a10ab4
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-10T18:02:11Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-694f6ae05d04452a82b535d441a10ab42023-11-20T08:45:11ZengMDPI AGPharmaceuticals1424-82472020-08-0113817810.3390/ph13080178Resistance to Acetylsalicylic Acid in Patients with Coronary Heart Disease Is the Result of Metabolic Activity of PlateletsYuriy I. Grinshtein0Andrei A. Savchenko1Aleksandra A. Kosinova2Maxim D. Goncharov3Therapeutic Department of Institute of Postgraduate Education, Krasnoyarsk State Medical University Named After Prof. V.F. Voyno-Yaseneckiy, 660125 Krasnoyarsk, RussiaTherapeutic Department of Institute of Postgraduate Education, Krasnoyarsk State Medical University Named After Prof. V.F. Voyno-Yaseneckiy, 660125 Krasnoyarsk, RussiaTherapeutic Department of Institute of Postgraduate Education, Krasnoyarsk State Medical University Named After Prof. V.F. Voyno-Yaseneckiy, 660125 Krasnoyarsk, RussiaTherapeutic Department of Institute of Postgraduate Education, Krasnoyarsk State Medical University Named After Prof. V.F. Voyno-Yaseneckiy, 660125 Krasnoyarsk, RussiaSensitivity to acetylsalicylic acid (ASA) is important in the treatment of patients with coronary heart disease (CHD) after coronary artery bypass grafting (CABG). Patients were divided into ASA sensitive (sASA) and ASA resistant (rASA) by the activity of platelet aggregation induced arachidonic acid (ARA) together with ASA. Induced platelet aggregation activity was studied in sASA and rASA patients with CHD before and after CABG. The level of synthesis of primary and secondary reactive oxygen species (ROS) by platelets was determined using chemiluminescent analysis. The activity of NAD- and NADP-dependent dehydrogenases in platelets was determined by the bioluminescent method. It was found that the aggregation activity of platelets depended on the sensitivity of CHD patients to ASA and decreased during postoperative ASA therapy. The most pronounced differences in metabolic parameters of platelets in sASA and rASA patients were detected by Nox2 activity. The synthesis of secondary ROS by platelets of CHD patients did not depend on the sensitivity of patients to ASA but increased during postoperative treatment with ASA. The activity of NAD(P)-dependent dehydrogenases in platelets did not differ in sASA and rASA patients with CHD.https://www.mdpi.com/1424-8247/13/8/178acetylsalicylic acid resistanceplateletsNox2reactive oxygen speciesdehydrogenase
spellingShingle Yuriy I. Grinshtein
Andrei A. Savchenko
Aleksandra A. Kosinova
Maxim D. Goncharov
Resistance to Acetylsalicylic Acid in Patients with Coronary Heart Disease Is the Result of Metabolic Activity of Platelets
Pharmaceuticals
acetylsalicylic acid resistance
platelets
Nox2
reactive oxygen species
dehydrogenase
title Resistance to Acetylsalicylic Acid in Patients with Coronary Heart Disease Is the Result of Metabolic Activity of Platelets
title_full Resistance to Acetylsalicylic Acid in Patients with Coronary Heart Disease Is the Result of Metabolic Activity of Platelets
title_fullStr Resistance to Acetylsalicylic Acid in Patients with Coronary Heart Disease Is the Result of Metabolic Activity of Platelets
title_full_unstemmed Resistance to Acetylsalicylic Acid in Patients with Coronary Heart Disease Is the Result of Metabolic Activity of Platelets
title_short Resistance to Acetylsalicylic Acid in Patients with Coronary Heart Disease Is the Result of Metabolic Activity of Platelets
title_sort resistance to acetylsalicylic acid in patients with coronary heart disease is the result of metabolic activity of platelets
topic acetylsalicylic acid resistance
platelets
Nox2
reactive oxygen species
dehydrogenase
url https://www.mdpi.com/1424-8247/13/8/178
work_keys_str_mv AT yuriyigrinshtein resistancetoacetylsalicylicacidinpatientswithcoronaryheartdiseaseistheresultofmetabolicactivityofplatelets
AT andreiasavchenko resistancetoacetylsalicylicacidinpatientswithcoronaryheartdiseaseistheresultofmetabolicactivityofplatelets
AT aleksandraakosinova resistancetoacetylsalicylicacidinpatientswithcoronaryheartdiseaseistheresultofmetabolicactivityofplatelets
AT maximdgoncharov resistancetoacetylsalicylicacidinpatientswithcoronaryheartdiseaseistheresultofmetabolicactivityofplatelets